Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yannick Allanore

Showing results (81-90 of 492) with videos related to

Pageof 50
Sort By:
The Journal of Rheumatology|September 17, 2010
High DNA oxidative damage in systemic sclerosisJerome Avouac, Didier Borderie, Ovanesse Garabed Ekindjian, et al.
Arthritis Research & Therapy|July 1, 2004
Nifedipine decreases sVCAM-1 concentrations and oxidative stress in systemic sclerosis but does not affect the concentrations of vascular endothelial growth factor or its soluble receptor 1Yannick Allanore, Didier Borderie, Hervé Lemaréchal, et al.
The Lancet. Rheumatology|March 20, 2024
Pre-scleroderma and new opportunities for preventive medicine - Authors' replyAlain Lescoat, Dinesh Khanna, Masataka Kuwana, et al.
Annals of the Rheumatic Diseases|June 7, 2020
Severe COVID-19-associated pneumonia in 3 patients with systemic sclerosis treated with rituximabJérôme Avouac, Paolo Airó, Nicolas Carlier, et al.
The American Journal of Medicine|April 20, 2004
Acute and sustained effects of dihydropyridine-type calcium channel antagonists on oxidative stress in systemic sclerosisYannick Allanore, Didier Borderie, Hervé Lemaréchal, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 9, 2004
Lack of association of eNOS (G894T) and p22phox NADPH oxidase subunit (C242T) polymorphisms with systemic sclerosis in a cohort of French Caucasian patientsYannick Allanore, Didier Borderie, Hervé Lemaréchal, et al.
The Journal of Rheumatology|August 4, 2009
Vitamin D deficiency and insufficiency in 2 independent cohorts of patients with systemic sclerosisAlessandra Vacca, Catherine Cormier, Martina Piras, et al.
Clinical and Experimental Rheumatology|May 2, 2025
Risk factors associated with venous thromboembolism in rheumatoid arthritis in clinical practiceFiona Oudart, Marion Thomas, Alice Combier, et al.
Annals of the Rheumatic Diseases|July 21, 2012
Prostaglandin I(2) analogues enhance already exuberant Th17 cell responses in systemic sclerosisMarie-Elise Truchetet, Yannick Allanore, Elisa Montanari, et al.
Arthritis Research & Therapy|October 15, 2011
Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung diseaseMarie-Elise Truchetet, Nicolò C Brembilla, Elisa Montanari, et al.
Pageof 50

Showing results (81-90 of 492) with videos related to

Sort By:
Pageof 50
The Journal of Rheumatology|September 17, 2010
High DNA oxidative damage in systemic sclerosisJerome Avouac, Didier Borderie, Ovanesse Garabed Ekindjian, et al.
Arthritis Research & Therapy|July 1, 2004
Nifedipine decreases sVCAM-1 concentrations and oxidative stress in systemic sclerosis but does not affect the concentrations of vascular endothelial growth factor or its soluble receptor 1Yannick Allanore, Didier Borderie, Hervé Lemaréchal, et al.
The Lancet. Rheumatology|March 20, 2024
Pre-scleroderma and new opportunities for preventive medicine - Authors' replyAlain Lescoat, Dinesh Khanna, Masataka Kuwana, et al.
Annals of the Rheumatic Diseases|June 7, 2020
Severe COVID-19-associated pneumonia in 3 patients with systemic sclerosis treated with rituximabJérôme Avouac, Paolo Airó, Nicolas Carlier, et al.
The American Journal of Medicine|April 20, 2004
Acute and sustained effects of dihydropyridine-type calcium channel antagonists on oxidative stress in systemic sclerosisYannick Allanore, Didier Borderie, Hervé Lemaréchal, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 9, 2004
Lack of association of eNOS (G894T) and p22phox NADPH oxidase subunit (C242T) polymorphisms with systemic sclerosis in a cohort of French Caucasian patientsYannick Allanore, Didier Borderie, Hervé Lemaréchal, et al.
The Journal of Rheumatology|August 4, 2009
Vitamin D deficiency and insufficiency in 2 independent cohorts of patients with systemic sclerosisAlessandra Vacca, Catherine Cormier, Martina Piras, et al.
Clinical and Experimental Rheumatology|May 2, 2025
Risk factors associated with venous thromboembolism in rheumatoid arthritis in clinical practiceFiona Oudart, Marion Thomas, Alice Combier, et al.
Annals of the Rheumatic Diseases|July 21, 2012
Prostaglandin I(2) analogues enhance already exuberant Th17 cell responses in systemic sclerosisMarie-Elise Truchetet, Yannick Allanore, Elisa Montanari, et al.
Arthritis Research & Therapy|October 15, 2011
Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung diseaseMarie-Elise Truchetet, Nicolò C Brembilla, Elisa Montanari, et al.
Pageof 50